The news of Oppenheimer maintaining an Outperform rating and raising the price target for Exelixis is directly related to the company and is likely to have a positive impact on its stock price in the short term. Investors may see this as a sign of confidence in the company's performance and future prospects, leading to increased demand for the stock.